ATE509279T1 - Verfahren zur überprüfung und kontrolle des milchsäurefermentationsprozesses/stoffwechselpf devon aerober glukosefermentation in säugerorganismen - Google Patents
Verfahren zur überprüfung und kontrolle des milchsäurefermentationsprozesses/stoffwechselpf devon aerober glukosefermentation in säugerorganismenInfo
- Publication number
- ATE509279T1 ATE509279T1 AT06723195T AT06723195T ATE509279T1 AT E509279 T1 ATE509279 T1 AT E509279T1 AT 06723195 T AT06723195 T AT 06723195T AT 06723195 T AT06723195 T AT 06723195T AT E509279 T1 ATE509279 T1 AT E509279T1
- Authority
- AT
- Austria
- Prior art keywords
- agf
- mam
- individual
- devon
- metabolism
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 238000000855 fermentation Methods 0.000 title abstract 3
- 230000004151 fermentation Effects 0.000 title abstract 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract 2
- 239000008103 glucose Substances 0.000 title abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title 2
- 241000124008 Mammalia Species 0.000 title 1
- 235000014655 lactic acid Nutrition 0.000 title 1
- 239000004310 lactic acid Substances 0.000 title 1
- 230000004060 metabolic process Effects 0.000 title 1
- 238000012795 verification Methods 0.000 title 1
- 101000800498 Homo sapiens Transketolase-like protein 1 Proteins 0.000 abstract 2
- 102100033108 Transketolase-like protein 1 Human genes 0.000 abstract 2
- 239000012190 activator Substances 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000037353 metabolic pathway Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05004930A EP1701165A1 (de) | 2005-03-07 | 2005-03-07 | Therapeutischer und diagnostischer Gebrauch von TKTL1 sowie seiner Inhibitoren und Aktivatoren |
| EP05013170 | 2005-06-17 | ||
| PCT/EP2006/001951 WO2006094716A1 (en) | 2005-03-07 | 2006-03-03 | Method for ckecking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE509279T1 true ATE509279T1 (de) | 2011-05-15 |
Family
ID=36224891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06723195T ATE509279T1 (de) | 2005-03-07 | 2006-03-03 | Verfahren zur überprüfung und kontrolle des milchsäurefermentationsprozesses/stoffwechselpf devon aerober glukosefermentation in säugerorganismen |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7754437B2 (de) |
| EP (2) | EP2256500B1 (de) |
| JP (1) | JP5095600B2 (de) |
| AT (1) | ATE509279T1 (de) |
| AU (1) | AU2006222277B2 (de) |
| CA (1) | CA2600206C (de) |
| DK (2) | DK2256500T3 (de) |
| ES (1) | ES2480416T3 (de) |
| PL (2) | PL1856537T3 (de) |
| PT (1) | PT2256500E (de) |
| WO (1) | WO2006094716A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007013903A1 (de) | 2007-03-20 | 2008-09-25 | Coy, Johannes F., Dr. | Getränk |
| DE102010007243B4 (de) * | 2010-02-09 | 2011-11-17 | Frank Kischkel | Therapieoptimierung bei Krebspatienten durch Austesten von Therapiekombinationen mittels in vitro Testungen (Zusatz) |
| DE102011008016A1 (de) | 2011-01-06 | 2012-07-12 | Johannes F. Coy | Schokoladenmasse |
| DE102020116980A1 (de) * | 2020-06-27 | 2021-12-30 | TAVARGENIX GmbH | Verwendung von Co-Enzym-Antagonisten zur Stoffwechselverlangsamung |
| CN112730734A (zh) * | 2020-12-22 | 2021-04-30 | 河南星汉生物科技有限公司 | 一种葡萄糖发酵乳酸中发酵液残糖的检验方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4006219A (en) * | 1972-08-10 | 1977-02-01 | Ceres Pharmacal Company | Composition and method for countering effects of alcohol consumption |
| DE2834706A1 (de) * | 1978-08-08 | 1980-02-14 | Boehringer Mannheim Gmbh | Verfahren und reagens zur bestimmung von glutamat-oxalacetat-transaminase und glutamat-pyruvat-transaminase |
| US4594237A (en) * | 1984-04-16 | 1986-06-10 | Walter Ziegler | Method for testing chemical and biological substances |
| US6919185B2 (en) * | 2000-05-31 | 2005-07-19 | Bayer Aktiengesellschaft | Regulation of human transketolase-like enzyme |
| US7381713B2 (en) * | 2000-12-04 | 2008-06-03 | Sioan-Kettering Institute For Cancer Research | Treatment of cancer by reduction of intracellular energy and pyrimidines |
| ATE384804T1 (de) | 2002-04-19 | 2008-02-15 | Coy Johannes Dr | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG UND ZUR DETEKTION VON PROLIFERATIVEN STÖRUNGEN DIE MIT DER ÜBEREXPRESSION DES MENSCHLICHEN ßTRANSKETOLASE LIKE-1ß GENS IN ZUSAMMENHANG STEHEN |
-
2006
- 2006-03-03 JP JP2008500098A patent/JP5095600B2/ja active Active
- 2006-03-03 ES ES10009323.6T patent/ES2480416T3/es active Active
- 2006-03-03 US US11/571,205 patent/US7754437B2/en active Active
- 2006-03-03 CA CA2600206A patent/CA2600206C/en active Active
- 2006-03-03 PT PT100093236T patent/PT2256500E/pt unknown
- 2006-03-03 AU AU2006222277A patent/AU2006222277B2/en active Active
- 2006-03-03 DK DK10009323.6T patent/DK2256500T3/da active
- 2006-03-03 WO PCT/EP2006/001951 patent/WO2006094716A1/en not_active Application Discontinuation
- 2006-03-03 EP EP10009323.6A patent/EP2256500B1/de active Active
- 2006-03-03 AT AT06723195T patent/ATE509279T1/de active
- 2006-03-03 DK DK06723195.1T patent/DK1856537T3/da active
- 2006-03-03 EP EP06723195A patent/EP1856537B1/de active Active
- 2006-03-03 PL PL06723195T patent/PL1856537T3/pl unknown
- 2006-03-03 PL PL10009323T patent/PL2256500T3/pl unknown
-
2010
- 2010-05-28 US US12/790,257 patent/US11236381B2/en active Active
-
2020
- 2020-01-29 US US16/775,454 patent/US11359225B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20200248227A1 (en) | 2020-08-06 |
| US11359225B2 (en) | 2022-06-14 |
| US11236381B2 (en) | 2022-02-01 |
| WO2006094716A1 (en) | 2006-09-14 |
| EP1856537A1 (de) | 2007-11-21 |
| EP2256500A3 (de) | 2012-08-29 |
| JP5095600B2 (ja) | 2012-12-12 |
| PT2256500E (pt) | 2014-07-18 |
| CA2600206A1 (en) | 2006-09-14 |
| ES2480416T3 (es) | 2014-07-28 |
| EP1856537B1 (de) | 2011-05-11 |
| AU2006222277A1 (en) | 2006-09-14 |
| CA2600206C (en) | 2011-01-04 |
| EP2256500B1 (de) | 2014-04-23 |
| PL2256500T3 (pl) | 2014-10-31 |
| US20080095703A1 (en) | 2008-04-24 |
| PL1856537T3 (pl) | 2011-10-31 |
| US7754437B2 (en) | 2010-07-13 |
| EP2256500A2 (de) | 2010-12-01 |
| DK2256500T3 (da) | 2014-07-14 |
| DK1856537T3 (da) | 2011-07-18 |
| AU2006222277B2 (en) | 2011-04-07 |
| US20100240687A1 (en) | 2010-09-23 |
| JP2008531065A (ja) | 2008-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE509279T1 (de) | Verfahren zur überprüfung und kontrolle des milchsäurefermentationsprozesses/stoffwechselpf devon aerober glukosefermentation in säugerorganismen | |
| BRPI0418539A (pt) | sistema de teste de analito para a determinação da concentração de um analito em um fluido fisiológico | |
| WO2008064067A3 (en) | Method for the sequential analysis of different components in a single biological sample and reagents therefor | |
| WO2008133729A3 (en) | Sequential analysis of biological samples with intermediate bleaching of fluorescence detector | |
| ATE412905T1 (de) | Diagnoseverfahren für lebersteatose unter verwendung biochemischer marker | |
| Tulpule et al. | Primary cultures of astrocytes and neurons as model systems to study the metabolism and metabolite export from brain cells | |
| CL2008003629A1 (es) | Metodo de analisis microbiologico de muestras biologicas que comprende un primer intervalo de tiempo de incubacion, tras el cual las muestras que dividen en 3 categorias (positivas, negativas o inciertas) dependiendo de la cantidad de dioxido de carbono generado, y donde las muestra que presentan un contenido de dioxido de carbono comprendido entre un valor maximo y minimo (muestras inciertas), se someten a un segundo intervalo de tiempo de incubacion y asi categorizarlas como positivas o negativas. | |
| US9133501B2 (en) | Analysis of direct factor Xa inhibitors | |
| WO2017153992A1 (en) | Method and system for continuous biosensing | |
| MX2010010465A (es) | Metodo para la deteccion de igf1r/chr 15 en celulas tumorales circulantes mediante hibridacion fluorescente in situ. | |
| Rajan et al. | Monitoring pH, temperature and humidity in long-term stem cell culture in CO 2 incubator | |
| BRPI0607912A2 (pt) | ensaio para determinar a presença, ausência ou saúde de uma célula, analito, ácido nucléico ou microorganismo em uma amostra, sonda, métodos para selecionar um analito que se ligue a um composto, para determinar se um ácido nucléico de interesse interage com uma proteína de interesse em uma célula ou uma amostra invitro, e para determinar a presença ou ausência de um ou mais compostos alvo em uma amostra, kit para manchar células, analitos, ácidos nucléicos ou microorganismos em uma amostra, e, composto" | |
| GB2593360A (en) | Antimicrobial susceptibility assay and kit | |
| EP2723886B1 (de) | Bestimmung von direkten thrombininhibitoren in serum oder urin | |
| Lamboursain et al. | A lab‐built respirometer for plant and animal cell culture | |
| US20150093775A1 (en) | System and method for analyte sensing and monitoring | |
| ATE455867T1 (de) | Echtzeit-pcr unter zusatz von pyrophosphatase | |
| Robertson et al. | Measurement of mollicute growth by ATP-dependent luminometry | |
| Atmanto et al. | Culture media | |
| JP5021273B2 (ja) | 老化度の判断方法 | |
| WO2009011277A1 (ja) | 抗酸菌属細菌の検出および同定用オリゴヌクレオチド、およびその用途 | |
| He et al. | An Enzyme Kinetics-Based Laboratory Module Aimed at Introducing Undergraduates to High-Throughput Drug Screening | |
| WO2024218396A1 (en) | Method of measuring oxidative stress | |
| Neun et al. | Detection of Bacterial Contamination using Tryptic Soy Agar Plates and RPMI Suspension Tests for the Purposes of Determining Bacterial ID: Version 2 | |
| Brown | Measuring Metabolic Competency of HepaRG Cells as a Function of Collagen ECM Stiffness |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1856537 Country of ref document: EP |